Topica Pharmaceuticals Inc — Form D/A
Topica Pharmaceuticals Inc of LOS ALTOS, CA, a company, filed a Form D amendment with the SEC on 2013-06-10. The offering totals $36.3M, of which $31.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-06-10
- Form: D/A
- Accession: 0001533299-13-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $36.3M
- Amount sold: $31.5M
- Remaining: $4.7M
- Investors: 11
- Date of first sale: 2011-10-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-167801
Issuer
- Name: Topica Pharmaceuticals Inc
- CIK: 0001533299
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 4300 EL CAMINO REAL, LOS ALTOS, CA, 94022
- Phone: 650-209-3711
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| David Kirk Cohen, MD | Director | LOS ALTOS, CA |
| Russell Gregory Hirsch, MD, Ph.D. | Director | LOS ALTOS, CA |
| Charles Gregory Homcy, MD | Director | LOS ALTOS, CA |
| G. Kirk Raab | Director | LOS ALTOS, CA |
| Charles Gregory Vontz | Director | LOS ALTOS, CA |
| Joseph Kirk Golemme | Executive Officer | LOS ALTOS, CA |
| Charles Gregory Vontz | Executive Officer | LOS ALTOS, CA |
| Charles Gregory Homcy MD | Director | Palo Alto, CA |
| Joseph E Golemme | Executive Officer | Palo Alto, CA |
| Alex Gregory Barkas | Director | Palo Alto, CA |
| Catherine E De Porceri-Morton | Executive Officer | Palo Alto, CA |
| David E Cohen MD MPH | Director | Palo Alto, CA |
| Norifumi E Nakamura | Executive Officer | Palo Alto, CA |
Other filings by this issuer (1)
More